Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin plus Omacor versus simvastatin plus placebo in mixed dyslipidemia
2006-003544-27Phase 2Active
- Sponsor
- Provident Clinical Research & Consulting, Inc.
- Start
- Jul 2006
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of omega-3-acid triglycerides and simvastatin in combined dyslipidaemia and dyslipidemia (2 arms), sponsored by Provident Clinical Research & Consulting, Inc. Primary endpoint: Percent change from baseline in non-HDL cholesterol. Started Jul 2006; status: active.
02
Drugs
omega-3-acid triglyceridessimvastatin
03
Conditions
combined dyslipidaemiadyslipidemia
Beyond the preview
Go deeper on 2006-003544-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003544-27.